Home
>
National Drug Code (NDC)
>
VICTRELIS
VICTRELIS - 0085-0314-02 - (BOCEPREVIR)
Drug Information of VICTRELIS
| Product NDC: | 0085-0314 |
| Proprietary Name: | VICTRELIS |
| Non Proprietary Name: | BOCEPREVIR |
| Active Ingredient(s): | 200 mg/1 & nbsp; BOCEPREVIR |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VICTRELIS
| Product NDC: | 0085-0314 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202258 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110513 |
Package Information of VICTRELIS
| Package NDC: | 0085-0314-02 |
| Package Description: | 4 TRAY in 1 CARTON (0085-0314-02) > 7 BOTTLE in 1 TRAY > 12 CAPSULE in 1 BOTTLE |
NDC Information of VICTRELIS
| NDC Code | 0085-0314-02 |
| Proprietary Name | VICTRELIS |
| Package Description | 4 TRAY in 1 CARTON (0085-0314-02) > 7 BOTTLE in 1 TRAY > 12 CAPSULE in 1 BOTTLE |
| Product NDC | 0085-0314 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BOCEPREVIR |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110513 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | BOCEPREVIR |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HCV NS3/4A Protease Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
